000			01611 a2200445 4500
005			20250514015921.0
264		0	_c20020117
008			200201s 0 0 eng d
022			_a0269-4727
024	7		_a10.1046/j.1365-2710.2001.00377.x _2doi
040			_aNLM _beng _cNLM
100	1		_aTremlett, H L
245	0	0	_aPrescribing for multiple sclerosis patients in general practice: a case-control study. _h[electronic resource]
260			_bJournal of clinical pharmacy and therapeutics _cDec 2001
300			_a437-44 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aCase-Control Studies
650	0	4	_aDepression _xetiology
650	0	4	_aDrug Prescriptions _xstatistics & numerical data
650	0	4	_aDrug Therapy _xstatistics & numerical data
650	0	4	_aFamily Practice
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aPractice Patterns, Physicians' _xstatistics & numerical data
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use
650	0	4	_aSex Factors
700	1		_aLuscombe, D K
700	1		_aWiles, C M
773	0		_tJournal of clinical pharmacy and therapeutics _gvol. 26 _gno. 6 _gp. 437-44
856	4	0	_uhttps://doi.org/10.1046/j.1365-2710.2001.00377.x _zAvailable from publisher's website
999			_c11636912 _d11636912